ABOUT US
20/20 Onsite is a healthcare services company providing clinical trial solutions that transform the delivery of vision care by radically improving patient access through state-of-the-art Mobile Vision Clinics. 20/20 Onsite's integrated point-of-need service delivery platform has taken high-value eye assessment services directly to patients at work, at school, in neighborhoods, and at clinical research sites. During the pandemic, 20/20 Onsite began bringing ophthalmic assessments to patients in clinical trials or post-marketing safety surveillance programs nationwide, increasing access to clinical research. 20/20 Onsite enables and accelerates fundamental trends toward the consumerization of care and the decentralization of clinical trials.
20/20 Onsite has served over 85,000 patients, including 22 clinical trials, met 100% of screening timelines across operations, and consistently reports patient NPS scores of over 94.
FEATURED ARTICLES
-
![2020 Onsite What We Do Josh Anderson]( "What Sponsors Must Know To Safeguard Ocular Endpoints")
Explore the necessity of incorporating imaging methodologies early in the trial design to improve data quality and overall trial efficiency.
-
![GettyImages-1819626829 patient recruitment]( "Clinical Trial Design Strategies To Improve Patient Retention")
While clinical trial planning often emphasizes rapid enrollment, sustained patient retention is equally vital to success.
-
![eye drops-GettyImages-1406386094]( "Critical Imaging Risks In GLP-1 And Neurology Studies")
As imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that safeguards participant safety and supports robust, reproducible outcomes.
-
![2025 business outlook-GettyImages-2179048246]( "What Clinical Trial Decision Makers Are Prioritizing In 2025")
In 2025, clinical trial operations are undergoing a transformative shift driven by the need for speed, cost-efficiency, and patient-centered approaches.
-
![20 20 onsite]( "High Density, Low Availability: Rethinking Ophthalmic Trial Readiness")
The adoption of mobile ophthalmic solutions and collaboration with specialized vendors is recommended to ensure trial consistency and reach underserved regions.
-
![GettyImages-1279370267 opthalmic study]( "The Hidden Complexity Of Ophthalmic Protocol Requirements")
Explore the critical role of meticulously planning ophthalmic assessments in clinical trials, highlighting their potential risks and complexities.
-
![2020 Onsite eye exam]( "The Implications Of Semaglutide's Connect To Increased Risk Of NAION")
Explore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).
-
![eye drops-GettyImages-1406386094]( "Why Mobile Eye Exams Are Critical In Clinical Trials With Ocular Endpoints")
Explore how mobile eye exams can expand access to eye care and improve the geographical reach of clinical trials.
-
![2020 onsite eye care]( "How Decentralized Clinical Trials Can Improve Data And Save Money")
Decentralized clinical trials are revolutionizing research by accelerating timelines, improving data collection, and enhancing patient retention.
-
![20_20 lab interior]( "Overcoming The Blind Spot In Clinical Trials")
Travel remains the leading barrier to patient participation. Mobile eye exams are transforming clinical trials by reducing this distance to just 13 miles, significantly enhancing patient retention.
VIDEOS AND WEBINARS
CONTACT INFORMATION
20/20 Onsite
29 Garden Street
Everett, MA 02149
UNITED STATES
Phone: 617-812-9453
Contact: Jessica McKenzie, Vice President, Life Sciences
FEATURED CASE STUDIES
-
![GettyImages-1391164235 eye disease]( "Enhancing Phase 1 Clinical Trials With Point-Of-Need Safety Assessments")
A Mobile Clinical Suite (MCS) proved to be the solution that Syneos Health needed to resolve their Phase 1 study trial challenges with comprehensive eye exams.
-
![Streamlining Phase 1 Trials with the Mobile Vision Pod]( "Streamlining Phase 1 Trials With The Mobile Vision Pod")
A contract research organization formed a partnership to address significant challenges during a Phase 1 clinical trial for a corneal disease treatment through the use of a Mobile Vision Pod.
-
![Expanding Diabetes-Related Eye Health Equity]( "Expanding Diabetes-Related Eye Health Equity")
20/20 Onsite, American Diabetes Association and Genentech collaborated on an event to provide immediate diagnostic services, including retinal imaging and visual acuity assessments, directly on-site.
-
![Expanding Access to Post-Market Safety]( "Expanding Access To Post-Market Safety Exams For Cystic Fibrosis Medication")
This study highlights the transformative impact of point-of-need care on patient access, focusing on pediatric cystic fibrosis (CF) patients requiring essential eye exams.
-
![Eye Care Delivered]( "Overcoming Unexpected Obstacles In A Phase 1 Study")
Discover how the implementation of mobile vision clinics (MVCs) was used to enhance efficiency in a Phase 1 clinical trial.
-
![IMG_6463]( "Advancing Rare Disease Clinical Trials With Point-Of-Need Eye Assessments")
During the COVID-19 pandemic, Applied Genetic Technologies Corporation (AGTC) faced significant hurdles in enrolling participants due to travel restrictions and site limitations.
-
![2020-onsite vehicle]( "Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments")
Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties
